Movers in Medicine

New ASBMT president takes the helm, more hem/onc appointments


 

Navneet Majhail, MD, president-elect of the American Society for Blood and Marrow Transplantation (ASBMT), will assume the office of ASBMT president at the end of February 2019.

Current ASBMT President John F. DiPersio, MD, recently announced he will be “handing over the baton” to Dr. Majhail at the Transplantation & Cellular Therapy Meetings (formerly BMT Tandem Meetings), scheduled to take place Feb. 20-24, 2019.

Dr. Majhail is director of the Cleveland Clinic’s Blood & Marrow Transplant Program, a staff physician in the department of hematology and oncology at the Taussig Cancer Institute, and a professor of medicine at the Cleveland Clinic Lerner College of Medicine.

Dr. Girish Dhall, University of Alabama

Dr. Girish Dhall

In other news, Girish Dhall, MD, has been named division director for the Hematology-Oncology and Blood Marrow Transplantation program at the University of Alabama at Birmingham department of pediatrics and Children’s of Alabama.

Dr. Dhall is currently a pediatric hematologist-oncologist and director of the Neuro-oncology Program at Children’s Hospital of Los Angeles. He is also an associate professor of clinical pediatrics at Keck School of Medicine at the University of Southern California. Dr. Dhall is slated to assume his new position at the end of May 2019.

Dr. Aaron Schimmer, Princess Margaret Cancer Centre in Toronto Courtesy the Princess Margaret Cancer Foundation

Dr. Aaron Schimmer

Aaron Schimmer, MD, PhD, has been appointed the new research director of Princess Margaret Cancer Centre in Toronto. The appointment is set to take effect Feb. 15, 2019.

Dr. Schimmer is an associate professor at the University of Toronto and a staff physician and senior scientist at the Princess Margaret Cancer Centre. He has served as the interim associate director of research at Princess Margaret since January 2018.

Dr. Charles M. Farber, Atlantic Health System Cancer Care, Morristown, N.J.

Dr. Charles M. Farber

Charles M. Farber, MD, PhD, and Michael Anthony Scola, MD, have joined Atlantic Hematology Oncology, part of Atlantic Health System Cancer Care. Their offices are located at the Carol G. Simon Cancer Center at Morristown Medical Center in New Jersey.


Dr. Michael Anthony Scola, Atlantic Health System Cancer Care, Morristown, N.J.

Dr. Michael Anthony Scola

Dr. Scola, an oncologist/hematologist, has been appointed director of the Atlantic Thrombosis Center, a program focused on thrombotic risk, events, and disorders. Dr. Farber, an oncologist specializing in malignant hematology, has been appointed medical director of Oncology Research Network Development for Atlantic Health System.

Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com , and you could be featured in Movers in Medicine.

Next Article: